Kamada Ltd. (TLV:KMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 2,487.00
+59.00 (2.43%)
Aug 28, 2026, 1:44 PM IDT
Kamada Revenue
Kamada had revenue of $54.92M USD in the quarter ending June 30, 2026, with 22.72% growth. This brings the company's revenue in the last twelve months to $191.85M, up 13.17% year-over-year. In the year 2025, Kamada had annual revenue of $180.46M with 12.12% growth.
Revenue (ttm)
$191.85M
Revenue Growth
+13.17%
P/S Ratio
2.45
Revenue / Employee
$415.26K
Employees
462
Market Cap
1.40B ILS
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 180.46M | 19.51M | 12.12% |
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
| Dec 31, 2019 | 127.19M | 12.72M | 11.11% |
| Dec 31, 2018 | 114.47M | 11.64M | 11.32% |
| Dec 31, 2017 | 102.83M | 25.33M | 32.69% |
| Dec 31, 2016 | 77.49M | 7.59M | 10.85% |
| Dec 31, 2015 | 69.91M | -1.16M | -1.63% |
| Dec 31, 2014 | 71.07M | 442.00K | 0.63% |
| Dec 31, 2013 | 70.62M | -2.05M | -2.82% |
| Dec 31, 2012 | 72.68M | 13.19M | 22.18% |
| Dec 31, 2011 | 59.48M | 25.01M | 72.53% |
| Dec 31, 2010 | 34.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 885.35M |
| SofWave Medical | 310.85M |
| InterCure | 270.20M |
| BrainsWay | 180.82M |
Kamada News
- 11 days ago - Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026 - GlobeNewsWire
- 11 days ago - Kamada CFO Chaime Orlev to depart - TheFly
- 11 days ago - Kamada reports Q2 EPS 16c, consensus 11c - TheFly
- 11 days ago - Kamada backs FY26 revenue view $200M-$205M - TheFly
- 13 days ago - Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes" - Nasdaq
- 15 days ago - Kamada Q2 Earnings Call Highlights - MarketBeat
- 15 days ago - Kamada Q2 2026 EPS Tops Expectations, Revenue Up 23% - AlphaStreet
- 16 days ago - Kamada Earnings Call Transcript: Q2 2026 - Transcripts